A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

NCT06153095 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Systemic Lupus Erythematosus
Lupus Nephritis

Interventions

BIOLOGICAL: IMPT-514
BIOLOGICAL: IMPT-514
BIOLOGICAL: IMPT-514

Sponsor

Lyell Immunopharma, Inc.